|
|
China Medical Acquires HPV Diagnostic Test for $345 Million
publication date: Oct 7, 2008
China Medical Technologies, which produces in-vitro diagnostic products, will pay $345 million to purchase the rights for a human papillomavirus (HPV) test from Molecular Diagnostics Technologies Limited. China Medical will buy the HPV-DNA Biosensor Chip and Surface Plasmon Resonance-based Analysis System (the SPR System), which can detect the virus that causes cervical cancer and sexually transmitted disorders. China Medical has profited by acquiring other in vitro technologies, most recently the FISH (Fluorescent in situ Hybridization) system. The SPR System will become part of the company’s FISH offerings. More details...
Stock Symbol: (NSDQ: CMED)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|